Back to results
US 2011/0218242 A1Published application
Polyunsaturated Fatty Acids for Treatment of Dementia and Pre-Dementia-Related Conditions
OwnerLorie A. ELLISinventor
Life of this patent
Estimating the term…
Abstract
Disclosed are compositions and methods for treating or preventing dementia and pre-dementia-related conditions and/or symptoms or characteristics of such conditions.
Claims27
1-63. (canceled)
A method of treating a human with age-related cognitive decline, comprising:
- administering to a human in need thereof a therapeutically effective amount of an oral dosage formulation comprising docosahexaenoic acid (DHA) and docosapentaenoic acid n-6 (DPAn-6), wherein the DHA and DPAn-6 are in a ratio from about 1:1 to about 10:1.
A method of treating a human with age-related cognitive decline, comprising:
- administering to a human in need thereof a therapeutically effective amount of an oral dosage formulation comprising docosahexaenoic acid (DHA), wherein the formulation comprises eicosapentaenoic acid (EPA) in an amount of about 1.36% or less as a percentage of total fatty acids.
A method of treating a human with age related cognitive decline, comprising:
- administering to a human in need thereof an oral dosage formulation comprising 40% or more by weight of DHA, wherein the DHA is administered in an amount from about 50 mg per day to about 20 grams per day.
Dependencies are inferred from the claim text.